Close Menu

The Next Bubble?

One of the next bubbles to hit may be genomics, says Alex Planes at The Motley Fool. The field is growing quickly, Planes notes, with more and more companies coming online and treatments and diagnostics starting to make their way to market — all driven by the steep decline of sequencing costs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.